TP53 and cancer: Glycolysis was upregulated in the PI3K signaling pathway alterations group compared with the no-alterations group in 12 types of cancer; it was also upregulated in the cell cycle, tumor protein 53 (TP53), and Hippo signaling pathway alterations group compared with the no-alterations group in ten types of cancer (Figure 4b).